The Director shall designate or appoint an appointee in the Senior Executive Service or an appointee in a position at level 15 of the General Schedule (or equivalent) as the United States Interdiction Coordinator to perform the duties of that position described in paragraph (2) and such other duties as may be determined by the Director with respect to coordination of efforts to interdict illicit drugs from entering the United States.
The United States Interdiction Coordinator shall be responsible to the Director for-
The Director shall assign such permanent staff of the Office as he considers appropriate to assist the United States Interdiction Coordinator to carry out the responsibilities described in paragraph (2), and may request that appropriate National Drug Control Program agencies detail or assign staff to assist in carrying out such responsibilities.
The National Interdiction Command and Control Plan shall-
Before submission of the National Drug Control Strategy or annual assessment required under section 1705 of this title, as applicable, the United States Interdiction Coordinator shall issue the National Interdiction Command and Control Plan in consultation with the other members of the Interdiction Committee described in subsection (b).
On or before September 1 of each year, the Director, acting through the United States Interdiction Coordinator, shall provide to the appropriate congressional committees, to the Committee on Armed Services and the Committee on Homeland Security of the House of Representatives, and to the Committee on Homeland Security and Governmental Affairs and the Committee on Armed Services of the Senate a report that-
Each report required to be submitted under subparagraph (C) shall be in unclassified form, but may include a classified annex.
The Interdiction Committee shall meet to-
The Director shall designate one of the members of the Interdiction Committee to serve as Chairperson.
The members of the Interdiction Committee shall meet, in person and not through any delegate or representative, at least once per calendar year, before June 1. At the call of the Director or the Chairperson, the Interdiction Committee may hold additional meetings, which shall be attended by the members in person, or through such delegates or representatives as the members may choose.
Not later than September 30 of each year, the Chairperson of the Interdiction Committee shall submit to the Director and to the appropriate congressional committees a report describing the results of the meetings and any significant findings of the Committee during the previous 12 months. The report required under this paragraph shall be in unclassified form, but may include a classified annex.
The Director may facilitate international drug control coordination efforts.
21 U.S.C. § 1710
EDITORIAL NOTES
REFERENCES IN TEXTThe General Schedule, referred to in subsec. (a)(1), is set out under section 5332 of Title 5, Government Organization and Employees.
PRIOR PROVISIONSA prior section 711, Oct. 21, 1998 of Pub. L. 105-277, 112 Stat. 2681-691; Pub. L. 105-277, div. C, title VII, §715, Oct. 21, 1998, 112 Stat. 2681-693; Pub. L. 109-469, title VI, §602, Dec. 29, 2006, 120 Stat. 3553, related to drug interdiction, prior to repeal by Pub. L. 115-271, title VIII, §8219(a), Oct. 24, 2018, 132 Stat. 4132. See 2018 and 2006 Amendment notes below.
AMENDMENTS2018- Pub. L. 115-271, §8219(a), repealed Pub. L. 105-277, div. C, title VII, §711, Oct. 21, 1998, 112 Stat. 2681-691. See 2006 Amendment note below. Pub. L. 115-271, §8202(b)(2), repealed Pub. L. 105-277, §715. See 1998 Amendment note below. Pub. L. 115-271, §8202(a), revived and restored this section as in effect on Sept. 29, 2003, and as amended by Pub. L. 109-469 and Pub. L. 112-166. See Reauthorization of the Office of National Drug Control Policy note set out under section 1701 of this title.Subsec. (a)(1). Pub. L. 115-271, §8219(b)(1)(A), substituted "The Director shall designate or appoint an appointee in the Senior Executive Service or an appointee in a position at level 15 of the General Schedule (or equivalent) as the United" for "The United" and "to perform" for "shall perform".Subsec. (a)(2)(B). Pub. L. 115-271, §8219(b)(1)(B), substituted "September 1" for "March 1" and "paragraph (4)" for "paragraph (3)".Subsec. (a)(3). Pub. L. 115-271, §8219(b)(1)(C), struck out "also, at his discretion," after "and may" and substituted "assist in carrying out such responsibilities" for "the Office of Supply Reduction for that purpose". Subsec. (a)(4)(B). Pub. L. 115-271, §8219(b)(1)(D)(i), substituted "Before submission of the National Drug Control Strategy or annual assessment required under section 1705 of this title, as applicable, the United" for "The United".Subsec. (a)(4)(C). Pub. L. 115-271, §8219(b)(1)(D)(iv)(I), in introductory provisions, substituted "September 1" for "March 1" and "a report that" for ",which shall include", inserted "the Director, acting through" after "each year," and a comma after "Coordinator", and struck out "a report on behalf of the Director" after "shall provide". Pub. L. 115-271, §8219(b)(1)(D)(ii), (iii), redesignated subpar. (D) as (C) and struck out former subpar. (C). Prior to amendment, text of subpar. (C) read as follows: "The National Interdiction Command and Control Plan shall not change existing agency authorities or the laws governing interagency relationships, but may include recommendations about changes to such authorities or laws."Subsec. (a)(4)(C)(i). Pub. L. 115-271, §8219(b)(1)(D)(iv)(II), (III), inserted cl. (i) designation and introductory provisions and redesignated former cls. (i) to (iii) as subcls. (I) to (III), respectively, of cl. (i).Subsec. (a)(4)(C)(i)(I). Pub. L. 115-271, §8219(b)(1)(D)(iv)(IV)(aa), inserted ",including information about how each National Drug Control Program agency conducting drug interdiction activities is engaging with relevant international partners" after "Plan".Subsec. (a)(4)(C)(i)(II). Pub. L. 115-271, §8219(b)(1)(D)(iv)(IV)(bb), substituted "and statistical" for ",as well as statistical". Subsec. (a)(4)(C)(i)(III). Pub. L. 115-271, §8219(b)(1)(D)(iv)(IV)(cc), substituted "and statistical" for ",as well as statistical" and ";and" for period at end. Subsec. (a)(4)(C)(ii). Pub. L. 115-271, §8219(b)(1)(D)(iv)(V), added cl. (ii). Former cl. (ii) redesignated subcl. (II) of cl. (i). Subsec. (a)(4)(C)(iii). Pub. L. 115-271, §8219(b)(1)(D)(iv)(II), redesignated cl. (iii) as subcl. (III) of cl. (i).Subsec. (a)(4)(D). Pub. L. 115-271, §8219(b)(1)(D)(v), added subpar. (D).Subsec. (b)(1)(B). Pub. L. 115-271, §8219(b)(2)(A), inserted "and how to strengthen international partnerships to better achieve the goals of that plan" after "that plan".Subsec. (b)(2). Pub. L. 115-271, §8219(b)(2)(B), substituted "Chairperson" for "Chairman" in heading and for "chairman" in text.Subsec. (b)(3). Pub. L. 115-271, §8219(b)(2)(C), substituted "before June 1" for "prior to March 1", "Chairperson" for "current chairman", and "the members may" for "they may" and struck out "either" after "the call of" and after "by the members".Subsec. (b)(4). Pub. L. 115-271, §8219(b)(2)(D), struck out "a report" after "shall submit", inserted "a report" after "committees", and substituted "Chairperson of the Interdiction Committee" for "chairman of the Interdiction Committee" and "The report required under this paragraph shall be in unclassified form, but may include a classified annex." for "Any content of such a report that involves information classified under criteria established by an Executive order, or whose public disclosure, as determined by the Director, the chairman, or any member, would be detrimental to the law enforcement or national security activities of any Federal, State, local, or tribal agency, shall be presented to Congress separately from the rest of the report."Subsec. (c). Pub. L. 115-271, §8219(b)(3), added subsec. (c). 2006- Pub. L. 109-469, §602, amended Pub. L. 105-277, §715, which provided for the repeal of this section. See 1998 Amendment note below. Pub. L. 109-469, §103(f)(1), directed that section 711 of Office of National Drug Control Policy Reauthorization Act of 1998 (Pub. L. 105-277 title VII) be amended by "adding at the end" a new section 711, which comprises this section. A prior section 711 of the Act was repealed by Pub. L. 115-271, §8219(a). See 2018 Amendment note above. 1998- Pub. L. 105-277, §715, as amended by Pub. L. 109-469, §602, which provided for the repeal of title VII of the Office of National Drug Control Policy Reauthorization Act of 1988 (Pub. L. 105-277 title VII) effective Sept. 30, 2010, was repealed by Pub. L. 115-271, §8202(b)(2). See former section 1712 of this title.
- Director
- The term "Director" means the Director of National Drug Control Policy.
- National Drug Control Program agency
- The term "National Drug Control Program agency" means any agency (or bureau, office, independent agency, board, division, commission, subdivision, unit, or other component thereof) that is responsible for implementing any aspect of the National Drug Control Strategy, including any agency that receives Federal funds to implement any aspect of the National Drug Control Strategy, but does not include any agency that receives funds for drug control activity solely under the National Intelligence Program or the Joint Military Intelligence Program.
- National Drug Control Program
- The term "National Drug Control Program" means programs, policies, and activities undertaken by National Drug Control Program agencies pursuant to the responsibilities of such agencies under the National Drug Control Strategy, including any activities involving supply reduction, demand reduction, or State, local, and tribal1 affairs.
- Office
- The term "Office" means the Office of National Drug Control Policy established under section 1702(a) of this title.
- drug control
- The term "drug control" means any activity conducted by a National Drug Control Program agency involving supply reduction or demand reduction.
- supply reduction
- The term "supply reduction" means any activity or program conducted by a National Drug Control Program agency that is intended to reduce the availability or use of illegal drugs in the United States or abroad, including-(A) law enforcement outside the United States;(B) domestic law enforcement;(C) source country programs, including economic development programs primarily intended to reduce the production or trafficking of illicit drugs;(D) activities to control international trafficking in, and availability of, illegal drugs, including-(i) accurate assessment and monitoring of international drug production and interdiction programs and policies; and(ii) coordination and promotion of compliance with international treaties relating to the production, transportation, or interdiction of illegal drugs;(E) activities to conduct and promote international law enforcement programs and policies to reduce the supply of drugs;(F) activities to facilitate and enhance the sharing of domestic and foreign intelligence information among National Drug Control Program agencies, relating to the production and trafficking of drugs in the United States and in foreign countries;(G) activities to prevent the diversion of drugs for their illicit use; and(H) research related to any of the activities described in this paragraph.1So in original. Probably should be "Tribal".